Key result
Men with prostate cancer on active surveillance had a 23% prevalence of clinical anxiety and 12.5% prevalence of depression, compared to 8% and 6% in the general population.
Why the study?
What is the prevalence of clinical depression and anxiety in men with prostate cancer undergoing active surveillance?
Population
313 men with a histological diagnosis of prostate cancer currently managed with active surveillance, mean…
Design
Cross-sectional
Authors
Loading...
Supports mental health screening consideration in active surveillance; leaves open prospective trials on intervention efficacy.
Cross-Sectional (n=313)
Yes
What is the prevalence of clinical depression and anxiety in men with prostate cancer undergoing active surveillance?
Absolute Event Rate: 23% vs 8%
Men with prostate cancer on active surveillance have significantly higher rates of anxiety and depression than the general population, highlighting the need for psychological support strategies.
Leydon et al. (2015) conducted a cross-sectional in Prostate cancer (n=313). Active surveillance vs. General population of similar age (published data) was evaluated on Prevalence of clinically meaningful anxiety and depression (HADS score ≥8/21). Men with prostate cancer on active surveillance had a 23% prevalence of clinical anxiety and 12.5% prevalence of depression, compared to 8% and 6% in the general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: